Next Generation Sequencing Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Opportunity Company Analysis
Buy NowNext Generation Sequencing (NGS) Market Outlook
Global Next Generation Sequencing (NGS) Market is predicted to be valued at around US$ 34.19 Billion by 2030, according to Renub Research. Next-generation sequencing (NGS) has revolutionized genomics, enabling speedy and excessive-throughput DNA sequencing. This advanced technology allows for parallel sequencing of several DNA fragments, remodeling genomics research, personalized medicinal drugs, and programs throughout biology, medicine, and agriculture. Techniques consisting of Illumina sequencing, which rose in the mid-2000s, have substantially reduced the time and cost of genetic studies, personalized medicine, and diagnostics. NGS's scalability and precision have redefined biology, driving information genetics, evolution, and ailment mechanisms breakthroughs.
Global Next Generation Sequencing (NGS) Market is anticipated to experience a CAGR of 18.16% from 2024 to 2030
The growing adoption of Next-Generation Sequencing (NGS) in scientific prognosis propels the worldwide NGS market expansion. NGS's capacity to offer comprehensive genetic statistics has unexpectedly improved its position in diagnosing various illnesses and assisting in personalized remedy decisions. The growing demand for precision medicinal drugs and improvements in genomic research expand NGS applications, fostering market growth. As NGS becomes necessary for medical workflows, its full use in diagnostics contributes drastically to the non-stop enlargement of the global market.
The market is growing because many companies are replacing outdated technology like microarrays with NGS, which gives superior accuracy, better throughput, and cost-effectiveness compared to standard methods. In 2022, a piece of writing published by Elsevier stated that NGS is advanced compared to microarrays in detecting DNA and appears to have other genomic obligations. As more and more businesses transfer from older technologies to NGS systems for genomic evaluation, the market is experiencing full-size growth. This shift highlights the vital position of NGS in advancing research, diagnostics, and personalized medicinal drugs, driving the continuous development of the next-era sequencing market.
North America and Europe are witnessing fast scientific trends in NGS methodologies for oncology and infectious disease applications. As researchers and healthcare experts seek complete solutions, NGS offerings, including sequencing and data interpretation, have become important. The advent of NGS panels, designed for focused sequencing of particular genomic regions, has revolutionized genetic analysis, imparting cost-effective and efficient solutions for various applications. Advancements in NGS technology and growing cognizance across various sectors make certain a promising future for genomics and precision medicine. Hence, the global next-generation sequencing (NGS) market was US$ 10.63 Billion in 2023.
Reagents and consumables sector accounted for a significant portion of the global next-generation sequencing market
By products, the global next-generation sequencing market is fragmented into Instruments, Reagents & Consumables, and Services. The reagents and consumables phase held one of the most significant shares in the global next-generation sequencing market. This, in particular, is attributed to the recurrent utilization and high demand for reagents and consumables in NGS's commercial and research applications. These consumables encompass sample preparation kits as well as kits for target enrichment. The adoption of NGS reagents and consumables has expanded as most pharmaceutical agencies and research institutes are utilizing NGS for several diagnostic programs and cancer studies.
Diagnostic application is one of the most critical segments in the global next-generation sequencing market
By application, the global next-generation sequencing market is segmented into Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others. Diagnostic applications are pivotal in the global Next-Generation Sequencing (NGS) market. This is due to their direct effect on healthcare. NGS's capability to research genetic versions enables precise disease prognosis, diagnosis, and personalized remedy selection. This section addresses important wishes in oncology, uncommon diseases, infectious illnesses, and prenatal screening, driving market increase. As healthcare structures prioritize precision medicine and genomic-pushed tactics, diagnostic applications become a cornerstone, contributing notably to the prominence and expansion of the global NGS market.
Sequencing by synthesis is one of the top technologies in the global market for next-generation sequencing
By technology, the global next-generation sequencing market is categorized into Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others. Sequencing by synthesis (SBS) is one of the most famous technologies in the global Next-Generation Sequencing (NGS) market. This technology permits immediate and correct sequencing by constructing complementary DNA strands step by step. Its significant use is pushed through its capability to utilize vast quantities of data, produce low mistake rates, and be cost-effective, making it ideal for various programs in studies, diagnostics, and customized medicine. As the desire for big-scale genomic evaluation continues to develop, SBS will remain an important technology, expanding the worldwide NGS market in the coming years.
Academic and clinical research centers are expected to be one of the fastest-growing segments in the global market
The end-users classify the global next-generation sequencing market into Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others. The academic and clinical research facilities segment is anticipated to be one of the quickest-growing segments within the market. This is due to the increasing use of next-generation sequencing (NGS) in cancer research. This technology enables the identification of new cancer-related genes, the examination of tumor heterogeneity, and the detection of alterations contributing to tumorigenesis. Also, providing scientific studies through market entities is predicted to offer ample opportunities for enhancing and detecting goals in this area.
United States will lead the global Next-Generation Sequencing (NGS) market
By countries, the global next-generation sequencing market is organized into North America (United States, Canada), Europe, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, United Arab Emirates). The global Next-Generation Sequencing (NGS) market is expected to be led by the United States. This is due to the country's advanced healthcare infrastructure, robust research capabilities, and significant investments in genomics. The US has created a favorable environment for NGS adoption, supported by extensive funding, a solid regulatory framework, and a thriving biotechnology industry. Predicine, Inc. announced in September 2022 regarding the PredicineCARETMcfDNA Assay. This is an NGS assay used for tumor mutation profiling in cfDNA. The cfDNA is isolated from liquid biopsy samples taken from cancer patients. The US FDA has granted this assay breakthrough device designation. This ensures its prominent role and leadership in the global NGS market.
Key Players
Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN N.V., Roche, Bio-Rad Laboratories, Inc., Takara Bio Inc., Hamilton Company, Geneious, and BioMérieux SA are the major companies in the global next-generation sequencing (NGS) market.
- In December 2023 - Illumina inscribed a memorandum of understanding with the African Society for Laboratory Medicine to improve access to genomics within the African region to combat infectious diseases.
- In March 2023 - The company SOPHiA GENETICS partnered with Qiagen to use QIAseq reagent technology with the DDM platform to improve tumor analysis using next-generation sequencing (NGS).
Renub Research report titled “Global Next-Generation Sequencing (NGS) Market By Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others),Countries (North America (United States, Canada), Europe, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (Saudi Arabia, United Arab Emirates, South Africa)) Company Analysis (Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN N.V., Roche, Bio-Rad Laboratories, Inc., Takara Bio Inc., Hamilton Company, Geneious, and BioMérieux SA)” provides a complete study of the Global Next-Generation Sequencing (NGS) Industry.
Product – Global Next-Generation Sequencing (NGS) Market breakup in 3 viewpoints:
1. Instruments
2. Reagents & Consumables
3. Services
Application – Global Next-Generation Sequencing (NGS) Market breakup in 5 viewpoints:
1. Diagnostics
2. Agriculture and Animal Research
3. Drug Discovery
4. Personalized Medicine and Genetic Screening
5. Others
Technology – Global Next-Generation Sequencing (NGS)Market breakup in 5 viewpoints:
1. Sequencing by Synthesis
2. Ion Semiconductor Sequencing
3. Single-Molecule Read Time Sequencing
4. Nanopore Sequencing
5. Others
End-Users – Global Next-Generation Sequencing (NGS) Market breakup in 4 viewpoints:
1. Academic and Clinical Research Centers
2. Pharmaceutical and Biotechnology Companies
3. Hospitals and Clinics
4. Others
Countries – Global Next-Generation Sequencing (NGS) Market of 25 Countries:
1 North America
1.1 United States
1.2 Canada
2 Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3 Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4 Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5 Middle East & Africa
5.1 Saudi Arabia
5.2 United Arab Emirates
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue Analysis
Company Analysis:
1. Illumina
2. Thermo Fisher Scientific
3. Pacific Biosciences
4. QIAGEN N.V.
5. Roche
6. Bio-Rad Laboratories, Inc.
7. Takara Bio Inc.
8. Hamilton Company
9. Geneious
10. BioMérieux SA
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2019 - 2023 |
| Forecast Period | 2024 - 2030 |
| Market | US$ Billion |
| Segment Covered | Product, Application, Technology, End-User, and Countries |
| Countries Covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherland, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa, and Rest of the World |
| Companies Covered | Beyond Meat, Conagra Brands, Maple Leaf Foods Inc, Tyson Foods Inc, Kellanavo, Archer Daniels Midland, US Foods Holding, and Hormel Foods Corporation |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Next Generation Sequencing Market
6. Market Share – Global Next Generation Sequencing Market
6.1 By Product
6.2 By Application
6.3 By Technology
6.4 By End User
6.5 By Countries
7. Product – Global Next Generation Sequencing Market
7.1 Instruments
7.2 Reagents & Consumables
7.3 Services
8. Application – Global Next Generation Sequencing Market
8.1 Diagnostics
8.2 Agriculture and Animal Research
8.3 Drug Discovery
8.4 Personalized Medicine and Genetic Screening
8.5 Others
9. Technology – Global Next Generation Sequencing Market
9.1 Sequencing by Synthesis
9.2 Ion Semiconductor Sequencing
9.3 Single Molecule Read Time Sequencing
9.4 Nanopore Sequencing
9.5 Others
10. End User – Global Next Generation Sequencing Market
10.1 Academic and Clinical Research Centers
10.2 Pharmaceutical and Biotechnology Companies
10.3 Hospitals and Clinics
10.4 Others
11. Countries – Global Next Generation Sequencing Market
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 South Africa
12. Porter's Five Forces Analysis – Global Next Generation Sequencing Market
12.1 Threat of New Entry
12.2 The Bargaining Power of Buyer
12.3 Threat of Substitution
12.4 The Bargaining Power of Supplier
12.5 Competitive Rivalry
13. SWOT Analysis – Global Next Generation Sequencing Market
13.1 Strengths
13.2 Weaknesses
13.3 Opportunities
13.4 Threats
14. Key Players Analysis
14.1 Illumina
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue
14.2 Thermo Fisher Scientific
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue
14.3 Pacific Biosciences
14.3.1 Overview
14.3.2 Recent Development
14.3.3 Revenue
14.4 QIAGEN N.V
14.4.1 Overview
14.4.2 Recent Development
14.4.3 Revenue
14.5 Roche
14.5.1 Overview
14.5.2 Recent Development
14.5.3 Revenue
14.6 Bio-Rad Laboratories, Inc.
14.6.1 Overview
14.6.2 Recent Development
14.6.3 Revenue
14.7 Takara Bio Inc
14.7.1 Overview
14.7.2 Recent Development
14.7.3 Revenue
14.8 Hamilton Company
14.8.1 Overview
14.8.2 Recent Development
14.8.3 Revenue
14.9 Geneious
14.9.1 Overview
14.9.2 Recent Development
14.9.3 Revenue
14.10 BioMérieux SA
14.10.1 Overview
14.10.2 Recent Development
14.10.3 Revenue
List of Figures:
Figure-01: Global – Next Generation Sequencing Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Next Generation Sequencing Market (Billion US$), 2024 – 2030
Figure-03: Product – Instruments Market (Million US$), 2019 – 2023
Figure-04: Product – Forecast for Instruments Market (Million US$), 2024 – 2030
Figure-05: Product – Reagents & Consumables Market (Million US$), 2019 – 2023
Figure-06: Product – Forecast for Reagents & Consumables Market (Million US$), 2024 – 2030
Figure-07: Product – Services Market (Million US$), 2019 – 2023
Figure-08: Product – Forecast for Services Market (Million US$), 2024 – 2030
Figure-09: Application – Diagnostics Market (Million US$), 2019 – 2023
Figure-10: Application – Forecast for Diagnostics Market (Million US$), 2024 – 2030
Figure-11: Application – Agriculture and Animal Research Market (Million US$), 2019 – 2023
Figure-12: Application – Forecast for Agriculture and Animal Research Market (Million US$), 2024 – 2030
Figure-13: Application – Drug Discovery Market (Million US$), 2019 – 2023
Figure-14: Application – Forecast for Drug Discovery Market (Million US$), 2024 – 2030
Figure-15: Application – Personalized Medicine and Genetic Screening Market (Million US$), 2019 – 2023
Figure-16: Application – Forecast for Personalized Medicine and Genetic Screening Market (Million US$), 2024 – 2030
Figure-17: Application – Others Market (Million US$), 2019 – 2023
Figure-18: Application – Forecast for Others Market (Million US$), 2024 – 2030
Figure-19: Technology – Sequencing by Synthesis Market (Million US$), 2019 – 2023
Figure-20: Technology – Forecast for Sequencing by Synthesis Market (Million US$), 2024 – 2030
Figure-21: Technology – Ion Semiconductor Sequencing Market (Million US$), 2019 – 2023
Figure-22: Technology – Forecast for Ion Semiconductor Sequencing Market (Million US$), 2024 – 2030
Figure-23: Technology – Single Molecule Read Time Sequencing Market (Million US$), 2019 – 2023
Figure-24: Technology – Forecast for Single Molecule Read Time Sequencing Market (Million US$), 2024 – 2030
Figure-25: Technology – Nanopore Sequencing Market (Million US$), 2019 – 2023
Figure-26: Technology – Forecast for Nanopore Sequencing Market (Million US$), 2024 – 2030
Figure-27: Technology – Others Market (Million US$), 2019 – 2023
Figure-28: Technology – Forecast for Others Market (Million US$), 2024 – 2030
Figure-29: End User – Academic and Clinical Research Centers Market (Million US$), 2019 – 2023
Figure-30: End User – Forecast for Academic and Clinical Research Centers Market (Million US$), 2024 – 2030
Figure-31: End User – Pharmaceutical and Biotechnology Companies Market (Million US$), 2019 – 2023
Figure-32: End User – Forecast for Pharmaceutical and Biotechnology Companies Market (Million US$), 2024 – 2030
Figure-33: End User – Hospitals and Clinics Market (Million US$), 2019 – 2023
Figure-34: End User – Forecast for Hospitals and Clinics Market (Million US$), 2024 – 2030
Figure-35: End User – Others Market (Million US$), 2019 – 2023
Figure-36: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-37: United States – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-38: United States – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-39: Canada – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-40: Canada – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-41: France – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-42: France – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-43: Germany – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-44: Germany – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-45: Italy – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-46: Italy – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-47: Spain – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-48: Spain – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-49: United Kingdom – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-50: United Kingdom – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-51: Belgium – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-52: Belgium – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-53: Netherlands – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-54: Netherlands – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-55: Turkey – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-56: Turkey – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-57: China – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-58: China – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-59: Japan – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-60: Japan – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-61: India – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-62: India – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-63: South Korea – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-64: South Korea – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-65: Thailand – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-66: Thailand – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-67: Malaysia – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-68: Malaysia – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-69: Indonesia – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-70: Indonesia – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-71: Australia – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-72: Australia – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-73: New Zealand – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-74: New Zealand – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-75: Brazil – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-76: Brazil – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-77: Mexico – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-78: Mexico – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-79: Argentina – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-80: Argentina – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-81: Saudi Arabia – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-82: Saudi Arabia – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-83: United Arab Emirates – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-84: United Arab Emirates – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-85: South Africa – Next Generation Sequencing Market (Million US$), 2019 – 2023
Figure-86: South Africa – Forecast for Next Generation Sequencing Market (Million US$), 2024 – 2030
Figure-87: Illumina – Global Revenue (Million US$), 2019 – 2023
Figure-88: Illumina – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-89: Thermo Fisher Scientific – Global Revenue (Million US$), 2019 – 2023
Figure-90: Thermo Fisher Scientific – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-91: Pacific Biosciences – Global Revenue (Million US$), 2019 – 2023
Figure-92: Pacific Biosciences – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-93: QIAGEN N.V – Global Revenue (Million US$), 2019 – 2023
Figure-94: QIAGEN N.V – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-95: Roche – Global Revenue (Million US$), 2019 – 2023
Figure-96: Roche – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-97: Bio-Rad Laboratories, Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-98: Bio-Rad Laboratories, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-99: Takara Bio Inc – Global Revenue (Million US$), 2019 – 2023
Figure-100: Takara Bio Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-101: Hamilton Company – Global Revenue (Million US$), 2019 – 2023
Figure-102: Hamilton Company – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-103: Geneious – Global Revenue (Million US$), 2019 – 2023
Figure-104: Geneious – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-105: BioMérieux SA – Global Revenue (Million US$), 2019 – 2023
Figure-106: BioMérieux SA – Forecast for Global Revenue (Million US$), 2024 – 2030
List of Tables:
Table-01: Global – Next Generation Sequencing Market Share by Product (Percent), 2019 – 2023
Table-02: Global – Forecast for Next Generation Sequencing Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Next Generation Sequencing Market Share by Application (Percent), 2019 – 2023
Table-04: Global – Forecast for Next Generation Sequencing Market Share by Application (Percent), 2024 – 2030
Table-05: Global – Next Generation Sequencing Market Share by Technology (Percent), 2019 – 2023
Table-06: Global – Forecast for Next Generation Sequencing Market Share by Technology (Percent), 2024 – 2030
Table-07: Global – Next Generation Sequencing Market Share by End User (Percent), 2019 – 2023
Table-08: Global – Forecast for Next Generation Sequencing Market Share by End User (Percent), 2024 – 2030
Table-09: Global – Next Generation Sequencing Market Share by Countries (Percent), 2019 – 2023
Table-10: Global – Forecast for Next Generation Sequencing Market Share by Countries (Percent), 2024 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com